Table 1

Statistics of the 24 candidate biomarkers for identifying breast cancer patients from healthy individuals
Mass Breast cancer Health Regulation in breast cancer P
Means SD Means SD
622.48 48.9 24.43 34.29 18.28 0.0454
622.97 48.26 24.67 30.41 14.76 0.013
654.73 27.08 9.66 18.02 5.6 0.0048
655.23 23.48 8.61 16.35 4.46 0.00827
666.78 13.96 6.64 20.73 6.29 0.00821
667.12 13.07 6.56 18.81 5.77 0.0146
676.83 39.48 25.42 15.69 15.75 1.98E-05
698.4 116.2 35.99 76.07 27.99 0.0048
698.81§ 114.32 35.83 70.97 23.34 0.00138
720.8§ 13.59 6.5 23.41 8.61 0.00199
721.4 13.31 6.39 19.92 7.96 0.0165
858.11 13.28 6.03 8.11 3.76 0.0182
887.23 10.15 3.38 8.33 5.93 0.0222
893.99 12.58 7.56 21.87 8.11 0.00218
909.06 27.78 15.1 40.15 14.33 0.0127
909.75 26.61 15.1 37.89 14.06 0.0222
1618.46 11.12 8.56 21.88 16.05 0.017
1866.64§ 6.66 5.23 12.97 7.21 0.00199
2770.34 6.64 5.11 2.26 1.07 0.00123
2771.86 5.73 4.78 1.48 0.68 0.000427
2933.97 3.69 2.06 1.86 0.85 0.0103
5963.91 0.71 0.76 0.2 0.24 0.0222
7772.04 0.73 0.94 0.25 0.46 0.0176
7777.16 0.8 1.01 0.3 0.51 0.0406

§The peptide selected for model construction.

Peak area.

P value calculated with the Wilcoxon test; values lower than 0.05 suggest statistical relevance.

Fan et al.

Fan et al. Diagnostic Pathology 2012 7:45   doi:10.1186/1746-1596-7-45

Open Data